Why weighing all of the ‘DE&I’ components is critical at site and sponsor levels.
Jamie Harper, MHA, CCRP
Advertisement
Vice President, Site Solutions and Engagement, WCG
Articles by Jamie Harper, MHA, CCRP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
2
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
3
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
4
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
5